Alpha-O Peptides ^Company

Alpha-O Peptides AG is a Swiss nano-biotechnology company that focuses on developing vaccines using proprietary self-assembling protein nanoparticles. Their most advanced vaccine has shown complete protection against malaria infection in animal models and has received support from NIH and the US Military Infectious Disease Research Program. They have also received grants for clinical trials for their nicotine vaccine. The company is also working on developing vaccines for cancer and other infectious diseases.